BioSpace News Archive

MediPines, the pioneering market leader in non-invasive pulmonary gas exchange technology, and maker of AGM100, will sponsor this year’s annual UCSD John B. West Distinguished Lecture event featuring Nobel Laureate Gregg L. Semenza, MD, PhD.

Nymox Pharmaceutical Corporation is pleased to announce an investment of US $2.0 million for 2 million shares at the price of $1.00 per share with 500,000 warrants priced at $2.00.

Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2023 on Wednesday, Aug. 9 at 9 a.m., ET.

Synaptive Medical has received $900,000 in support from the Ontario government through the Ontario Together Fund.

Celegence, a regulatory compliance service and software solution company, announced the launch of CAPTIS Copilot, the most advanced document automation and literature review solution for the life sciences industry.

Annexon, Inc. announced that it has granted an equity inducement award to Jamie Dananberg, M.D., the company’s Chief Medical Officer, under the terms of the 2022 Employment Inducement Award Plan.

Corcept Therapeutics Incorporated, a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism and neurology disorders by modulating the effects of the hormone cortisol, reported results for the quarter ended June 30, 2023.

Singular Genomics Systems, Inc. announced plans to participate in the UBS MedTech, Tools and Genomics Summit in Dana Point, California.

NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX) will report its financial results for the second quarter ended June 30, 2023 before market open on Thursday, August 17, 2023.

Roivant announced that it will redeem all of its outstanding public warrants and private placement warrants to purchase Roivant’s common shares pursuant to its Warrant Agreement dated September 30, 2021 with Equiniti Trust Company, LLC as successor warrant agent, that remain outstanding following 5:00 p.m. New York City Time on September 1, 2023 for a redemption price of $0.10 per Warrant.